Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres.

Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres.

There were approximately 10 million tuberculosis (TB) cases in 2020, of which 500,000 were drug-resistant. Only one third of drug-resistant TB cases were diagnosed and enrolled on appropriate treatment, an issue partly driven by a lack of rapid, accurate drug-susceptibility testing (DST) tools deplo...

Full description

Bibliographic Details
Main Authors: Emily Lai-Ho MacLean, Paolo Miotto, Lice González Angulo, Matteo Chiacchiaretta, Timothy M Walker, Martina Casenghi, Camilla Rodrigues, Timothy C Rodwell, Philip Supply, Emmanuel André, Mikashmi Kohli, Morten Ruhwald, Daniela Maria Cirillo, Nazir Ismail, Matteo Zignol
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLOS Global Public Health
Online Access:https://doi.org/10.1371/journal.pgph.0001754

Internet

https://doi.org/10.1371/journal.pgph.0001754

Similar Items